Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 202

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor

Open access
Kim, Yunjae, Kim, Gihyeon, Kim, Sujeong, Cho, Beomki, Kim, Sang-Yeob, Do, Eun-Ju, Bae, Dong-Jun, Kim, Seungil, Kweon, Mi-Na, Song, Joon Seon, Park, Sang Hyoung, Hwang, Sung Wook, Kim, Mi-Na, Kim, Yeongmin, Min, Kyungchan, Kim, Sung-Han, Adams, Mark D., Lee, Charles, Park, Hansoo, Park, Sook Ryun · 2024 · Cell Host & Microbe

Abstract

The gut microbiome significantly influences immune responses and the efficacy of immune checkpoint inhibitors. We conducted a clinical trial (NCT04264975) combining an anti-programmed death-1 (PD-1) inhibitor with fecal microbiota transplantation (FMT) from anti-PD-1 responder in 13 patients with anti-PD-1-refractory advanced solid cancers. FMT induced sustained microbiota changes and clinical benefits in 6 of 13 patients, with 1 partial response and 5 stable diseases, achieving an objective response rate of 7.7% and a disease control rate of 46.2%. The clinical response correlates with increased cytotoxic T cells and immune cytokines in blood and tumors. We isolated Prevotella merdae Immunoactis from a responder to FMT, which stimulates T cell activity and suppresses tumor growth in mice by enhancing cytotoxic T cell infiltration. Additionally, we found Lactobacillus salivarius and Bacteroides plebeius may inhibit anti-tumor immunity. Our findings suggest that FMT with beneficial microbiota can overcome resistance to anti-PD-1 inhibitors in advanced solid cancers, especially gastrointestinal cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chom.2024.06.010

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 202

Metadata

Authors
Kim, Y., Kim, G., Kim, S., Cho, B., Kim, S.-Y., Do, E.-J., Bae, D.-J., Kim, S., Kweon, M.-N., Song, J. S., Park, S. H., Hwang, S. W., Kim, M.-N., Kim, Y., Min, K., Kim, S.-H., Adams, M. D., Lee, C., Park, H., & Park, S. R.
Venue
Cell Host & Microbe
Publisher
Elsevier BV
Published
2024-08
Volume
32
Issue
8
Pages
1380-1393.e9
ISSN
1931-3128 (ISSN-L)
OpenAlex
W4400977720
Cited by
202
References
20
FWCI
30.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor. https://app.cochat.ai/papers/10.1016/j.chom.2024.06.010
The paper
Kim, Y., Kim, G., Kim, S., Cho, B., Kim, S.-Y., Do, E.-J., Bae, D.-J., Kim, S., Kweon, M.-N., Song, J. S., Park, S. H., Hwang, S. W., Kim, M.-N., Kim, Y., Min, K., Kim, S.-H., Adams, M. D., Lee, C., Park, H., & Park, S. R. (2024). Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2024.06.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.